All Phenotypes Rest<tm1.1Jhsi> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Rest^tm1.1Jhsi/Rest^tm1.1Jhsi	involves: 129S6/SvEvTac * C57BL/6 * SJL	MGI:5141117
cn2	Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Rest^tm1.1Jhsi/Rest^tm1.1Jhsi Tg(Nes-cre/ERT2)KEisc/0	involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * SJL	MGI:5141116
cn3	Rest^tm1.1Jhsi/Rest^tm1.1Jhsi Tg(CAG-cre)13Miya/0	involves: 129S6/SvEvTac * C57BL/6 * SJL	MGI:5141115

Allelic Composition	Rest^tm1.1Jhsi/Rest^tm1.1Jhsi
Genetic Background	involves: 129S6/SvEvTac * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rest^tm1.1Jhsi mutation (1 available); any Rest mutation (92 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

nervous system

abnormal neuron differentiation ( J:174056 )

• neurospheres treated with cre-expressing adenovirus exhibit reduced self-renewal capacity compared with wild-type cells

cellular

abnormal neuron differentiation ( J:174056 )

• neurospheres treated with cre-expressing adenovirus exhibit reduced self-renewal capacity compared with wild-type cells

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

nervous system

abnormal neuron differentiation ( J:174056 )

• 20 days after tamoxifen treatment, mice exhibit a transient increase in hippocampal neurogenesis compared with control mice

• tamoxifen-treatment increased hippocampal neurogenesis in vitro and in vivo compared with controls

• tamoxifen-treated mice exhibit premature exit of quiescence compared with control mice

• tamoxifen-treated mice exhibit loss of neurogenic capacity of adult neurospheres and decreased neurogenesis over time compared with control mice

• neurospheres treated from tamoxifen-treated mice exhibit reduced self-renewal capacity compared with wild-type cells

• however, hippocampal neurogenesis is normal 10 and 30 days after tamoxifen treatment

premature neuronal precursor differentiation ( J:174056 )

• in tamoxifen-treated mice

decreased neuron number ( J:174056 )

• tamoxifen-treated mice exhibit decreased adult-generated immature and mature granule neurons compared with control mice

cellular

abnormal neuron differentiation ( J:174056 )

• 20 days after tamoxifen treatment, mice exhibit a transient increase in hippocampal neurogenesis compared with control mice

• tamoxifen-treatment increased hippocampal neurogenesis in vitro and in vivo compared with controls

• tamoxifen-treated mice exhibit premature exit of quiescence compared with control mice

• tamoxifen-treated mice exhibit loss of neurogenic capacity of adult neurospheres and decreased neurogenesis over time compared with control mice

• neurospheres treated from tamoxifen-treated mice exhibit reduced self-renewal capacity compared with wild-type cells

• however, hippocampal neurogenesis is normal 10 and 30 days after tamoxifen treatment

premature neuronal precursor differentiation ( J:174056 )

• in tamoxifen-treated mice

Allelic Composition	Rest^tm1.1Jhsi/Rest^tm1.1Jhsi Tg(CAG-cre)13Miya/0
Genetic Background	involves: 129S6/SvEvTac * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rest^tm1.1Jhsi mutation (1 available); any Rest mutation (92 available)
Tg(CAG-cre)13Miya mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality, complete penetrance ( J:174056 )

• mice exhibit the same embryonic lethality phenotype as Rest^tm1And homozygotes

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 09/30/2025 MGI 6.24